225 related articles for article (PubMed ID: 2974299)
1. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
Bonati M; Traina GL; Rosina R; Buniva G
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.
Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M
Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
[TBL] [Abstract][Full Text] [Related]
6. Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.
Guay DR; Awni WM; Halstenson CE; Kenny MT; Keane WF; Matzke GR
Antimicrob Agents Chemother; 1989 Nov; 33(11):2012-5. PubMed ID: 2532874
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of teicoplanin.
Rowland M
Clin Pharmacokinet; 1990 Mar; 18(3):184-209. PubMed ID: 2138946
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
[TBL] [Abstract][Full Text] [Related]
11. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
Somani P; Shapiro RS; Stockard H; Higgins JT
Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
[TBL] [Abstract][Full Text] [Related]
13. Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspects.
Neville LO; Baillod R; Grady D; Brumfitt W; Hamilton-Miller JM
Int J Clin Pharmacol Res; 1987; 7(6):485-90. PubMed ID: 2964417
[TBL] [Abstract][Full Text] [Related]
14. Teicoplanin pharmacokinetics in patients with chronic renal failure.
Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
16. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
Clin Pharmacol Ther; 1983 Nov; 34(5):673-80. PubMed ID: 6313276
[TBL] [Abstract][Full Text] [Related]
17. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
Passlick J; Wonner R; Keller E; Essers L; Grabensee B
Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.
Keller E; Reetze P; Schollmeyer P
Clin Pharmacokinet; 1990 Feb; 18(2):104-17. PubMed ID: 2180611
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
